🇺🇸 FDA
Patent

US 10450352

Engineered polypeptides for antigen delivery

granted A61KA61K2039/6068A61K35/12

Quick answer

US patent 10450352 (Engineered polypeptides for antigen delivery) held by The Board of Regents of the University of Texas System expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/6068, A61K35/12, A61K35/66, A61K39/00